Ongoing Registry of Treatment of Venous Thromboembolism
- Conditions
- Thromboses, VenousDeep Vein ThrombosisPulmonary EmbolismThrombosis EmbolismPostthrombotic Syndrome
- Registration Number
- NCT03881345
- Lead Sponsor
- Medalp Private Surgery Clinic
- Brief Summary
Ongoing registration of patients with venous thromboembolism treated by means of antithrombotic therapy, thrombolisys, open surgery, endovenous desobstruction and stenting.
- Detailed Description
Data of patients with VTE treated in different Russian medical centers are entered in a prospective digital database, and continuously updated.
There is planned to conduct prospective randomized, cohort and observational studies on the site of register
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 5000
- case of venous thrombosis of a limb or pulmonary embolus
- no exclusion criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Veins patency Baseline, 3 and 12 months post-intervention Change in patency target veins assessed by duplex ultrasonography in different follow up periods due to different treatment methods
- Secondary Outcome Measures
Name Time Method QoL SF-36 Baseline, 3 and 12 months post-intervention Change in Quality of Life (QoL), assessed by "Short form 36" health survey (SF-36). Total scale range: from 0 to 800. SF-36 consists of 8 subscales. Each subscale range: 0 - 100. Subscales are combined using a special algorithm described in the instructions for the SF-36. For total scale the higher value represent the worse QoL.
Postthrombotic syndrome Baseline, 3 and 12 months post-intervention the presence and severity of postthrombotic syndrome on the Villalta scale
QoL AVVQ Baseline, 3 and 12 months post-intervention Change in Quality of Life (QoL), assessed by "Aberdeen Varicose Vein Questionnaire" (AVVQ). The AVVQ is a disease-specific QoL questionnaire aimed at venous disease. Total scale range: from 0 to 100, where the higher score represent worse QoL.
Trial Locations
- Locations (1)
Pirogov Russian National Research Medical University
🇷🇺Moscow, Russian Federation